HUMASIS CO., LTD. Logo

HUMASIS CO., LTD.

Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.

205470 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HUMASIS CO., LTD. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) medical devices. Since its establishment in 2000, the firm has concentrated on Point-of-Care Testing (POCT) solutions, delivering rapid and accurate diagnostic results. Its product portfolio includes a wide range of immunodiagnostic rapid test kits for the early screening of conditions such as infectious diseases, cardiac markers, and tumor markers. A key aspect of its strategy is the in-house development and production of core bio-materials, such as diagnostic antigens, to ensure the quality and accuracy of its kits. The company also provides compact diagnostic instruments for quantitative analysis. Humasis serves a global market, exporting its products to numerous countries with the goal of empowering individuals through accessible self-health management tools.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HUMASIS CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등)
Korean 21.0 KB

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884

Talk to a Data Expert

Have a question? We'll get back to you promptly.